Clarion Brands Argues NAD Turns Deaf Ear To Tinnitus Claims Review
This article was originally published in The Tan Sheet
Executive Summary
Clarion Brands appeals NAD’s recommendations to discontinue a testimonial and other claims that convey the message its Lipo-Flavonoid Plus substantially reduces or eliminates tinnitus and the symptoms of Ménière’s disease.
You may also be interested in...
Bridges Consumer Startup Reaches Brands For Specialty Conditions In Clarion Deal
Acquiring Clarion Brands from Swander Pace, Bridges Consumer Healthcare adds portfolio of OTC and supplement brands for symptoms including tinnitus, urinary pain relief and excessive sweating.
Hearing Supplement Improvement Claims Don't Echo Separate Ingredient Studies
National Advertising Division says Bel Marra Health's reliance on ingredient studies with dosage or usage that could not translate to the ingredients in the product failed to support its claims. “Without testing that the ingredients in the quantity found in Hearing Rescue have the claimed effect, the results from these studies cannot be used to support qualified claims that the same ingredients in the product reduce the damage caused by repeated noise exposure and improve hearing,” NAD said following a review from a challenge by the Council for Responsible Nutrition.
Nasacort, Flonase Competition Heats Up As Sanofi Appeals NAD Review
Chattem appeals a National Advertising Division decision from a review of advertising comparing its Nasacort nasal allergy spray to GSK’s Flonase. The Sanofi business maintains NAD relied on a “cookbook” approach to determine whether claims for the product are substantiated.